Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of November 24, 2024 • 9:00 AM ET
As of November 24, 2024 • 9:00 AM ET
Date/Time | Source | News Release |
---|---|---|
07/26/2022 08:02 AM EDT | SeekingAlpha | Organicell Regenerative Medicine names new CEO, COO |
05/19/2021 07:47 AM EDT | SeekingAlpha | Organicell signs exclusive distribution agreement with Apex Services in Pakistan |
04/21/2021 07:43 AM EDT | SeekingAlpha | Organicell's osteoarthritis treatment zofin IND gets FDA greenlight |
04/14/2021 07:42 AM EDT | SeekingAlpha | Organicell and Oklahoma State University team up in Zofin study |
03/23/2021 03:45 PM EDT | SeekingAlpha | Organicell Regenerative Medicine partners with CDC on Zofin's study for influenza |
01/28/2021 08:02 AM EST | SeekingAlpha | Organicell gets FDA greenlight for Zofin trials in COPD |
11/12/2020 08:03 AM EST | SeekingAlpha | Organicell advancing study of Zofin for COVID-19 |
09/29/2020 10:11 AM EDT | SeekingAlpha | Organicell Regenerative Medicine's Zofin nabs accelerated review in U.S. to treat COVID-19 patients |
08/18/2020 12:15 PM EDT | SeekingAlpha | Organicell to initiate early-stage study of its lead candidate for COVID-19 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.